Skip to main content
Fig. 2 | Molecular Medicine

Fig. 2

From: FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease

Fig. 2

FBXW7 alleviates insulin resistance in HFD-fed mouse livers (n = 4). a Data of glucose tolerance tests in different treatment groups. b Data of insulin tolerance tests in different treatment groups. c Immunoblotting and densitometry of p-Akt in mouse livers. d Immunoblotting and densitometry of p-GSK3β in mouse livers. All of the values are expressed as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 versus the ND + Ad-GFP group; #P < 0.05, ##P < 0.01, ###P < 0.001 versus the HFD + Ad-GFP group

Back to article page